The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
In what seems a significant step forward in pain management, the US Food and Drug Administration has approved a new non-opioid painkiller for treating short-term pain in adults. Veuer’s Maria Mercedes ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction of a first-in-class non-opioi ...
The recalled Braga Fresh Marketside Broccoli was washed, ready-to-eat, and sold in 12-ounce bags at Walmart stores in 20 states including Alaska, Arkansas, Arizona, California, Colorado, Idaho, ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
Unpatched vulnerabilities in Contec CMS8000 patient monitors expose devices to remote access, file overwrites, and data leaks ...
A chocolate-covered pretzel product is being recalled in three states due to the presence of an undeclared milk allergen.
More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...
Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi's Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. | Takeda is promoting U.S. chief Julie Kim ...
Meloxicam is a nonsteroidal, anti-inflammatory molecule developed with Axsome’s Molecular Solubility Enhanced Inclusion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback